Back

Volume 39 , Issue 3
May/June 2019
Pages 361–368

Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Hugo De Bruyn, DDS, MSc, PhD/Maarten Glibert, DDS, MSc/Liesbet Matthijs, DDS, MSc/Martens Filip, DDS, MSc/Véronique Christiaens, DDS, MSc/Luc Marks, DDS, MSc, PhD

PMID: 29590223
DOI: 10.11607/prd.3284

This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.